Funding Details
- Awarder
- Inbox
- Date Award
- March 22, 2017
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
Company Info
- Company Description
- BioClin Therapeutics, Inc. is a privately-held clinical stage drug development company developing biologics to address medical conditions in areas of high unmet need. The company's lead candidate is B-701, a potential first-in-class human monoclonal antibody targeting FGFR3, currently being evaluated in the treatment of metastatic bladder cancer.
- Market
- Pharmaceuticals
- Location
-
San Ramon,
California,
USA
- Coinvestors
- HealthCap, Life Sciences Partners, Sofinnova Ventures, Tekla Capital Management, Ysios Capital
Links